Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination.

Jongvilaikasem, Pondtip; Rianthavorn, Pornpimol

Jongvilaikasem, Pondtip; Rianthavorn, Pornpimol.

Jongvilaikasem P; Pediatric Division, Hat Yai Medical Education Center, Hat Yai Hospital, Songkhla, Thailand.
Rianthavorn P; Division of Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, 1873 King Rama 4 Road, Pathumwan, Bangkok, 10330, Thailand. pornpimol.r@chula.ac.th.

Pediatr Nephrol ; 37(6): 1419-1421, 2022 06.

Article in English | MEDLINE | ID: covidwho-1669812

Subject(s)

BNT162 Vaccine; COVID-19; Nephritis, Interstitial; Nephrosis, Lipoid; BNT162 Vaccine/adverse effects; COVID-19/prevention & control; Humans; Nephritis, Interstitial/chemically induced; Nephrosis, Lipoid/chemically induced; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / Nephritis, Interstitial / Nephrosis, Lipoid Type of study: Case report Topics: Vaccines Limits: Humans Language: English Journal: Pediatr Nephrol Journal subject: Nephrology / Pediatrics Year: 2022 Document Type: Article Affiliation country: S00467-022-05470-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google